A clinical mutation in glucokinase causing maturity-onset diabetes in the young type 2 increases enzyme activity
Abstract
Glucokinase (GCK) is the pancreatic ?-cell glucose sensor, and its kinetics are key to that purpose. A slow transition step, displayed as non-hyperbolic kinetics, and a low affinity for glucose characterize GCK. Mutations in GCK associated with maturity-onset diabetes of the young type 2 (MODY2) previously described reduce the functionality of the human pancreatic ?-cell, leading to diabetic clinical phenotypes. We present a kinetic characterization of the G448D mutation identified in a MODY2 patient, which is one of the first mutations to exhibit increased functionality. This mutant displays increased activity, high affinity for both Mg2+-ATP and glucose, hyperbolic kinetics and increased phosphorylation potential. Hyperbolic kinetics and assays in the presence of glycerol indicate that G448D lacks the slow transition step crucial for the pancreatic ?-cell glucose sensor function. © 2022 Federation of European Biochemical Societies.
Más información
| Título según WOS: | A clinical mutation in glucokinase causing maturity-onset diabetes in the young type 2 increases enzyme activity |
| Título según SCOPUS: | A clinical mutation in glucokinase causing maturity-onset diabetes in the young type 2 increases enzyme activity |
| Título de la Revista: | FEBS Letters |
| Volumen: | 597 |
| Número: | 11 |
| Editorial: | John Wiley and Sons Inc. |
| Fecha de publicación: | 2023 |
| Página de inicio: | 1469 |
| Página final: | 1478 |
| Idioma: | English |
| DOI: |
10.1002/1873-3468.14561 |
| Notas: | ISI, SCOPUS |